Liver Cancer Risk Persists Even Among Non-Drinkers, Vimut Hospital Warns

Bangkok: Not drinking alcohol or beer does not mean immunity to disease. People with factors such as diabetes, obesity, and fatty liver disease can still develop liver cancer. Doctors at Vimut Hospital highlight that these conditions can damage the liver without the need for alcohol consumption.

According to Thai News Agency, liver cancer is often linked to heavy and continuous alcohol consumption, yet it can occur in individuals with other risk factors. The disease is particularly concerning because it often presents no symptoms in its early stages, leading to late diagnosis when the cancer is already advanced.

Dr. Savinee Jiriyasin, a gastroenterology and hepatology specialist at Vimut Phaholyothin Hospital, explains that liver cancer arises from mutations in liver cells, leading to tumor formation. It is more prevalent in individuals aged 50-70 years due to the gradual development of chronic inflammation. The repeated damage and repair of liver cells increase the likelihood of mutation into cancer. Men face a 2-3 times higher risk than women, attributed to higher rates of hepatitis virus infection and alcohol consumption, along with potential stimulation by male hormones.

Dr. Sawinee emphasizes that liver cancer is a silent killer, often going unnoticed until it is incidentally discovered during screenings. She advises prompt check-ups for those at risk, asserting the importance of early detection for effective treatment.

Preventive measures include maintaining a healthy weight, hepatitis vaccination, and avoiding liver-harming behaviors like excessive alcohol consumption and processed foods. Dr. Sawinee urges regular screenings for at-risk individuals and stresses that liver care should be a personal priority, not limited to alcohol consumers.

Vimut Hospital offers comprehensive care for liver cancer patients with a multidisciplinary team and advanced diagnostic technologies, including ultrasound, CT scans, and MRI. Treatment plans are personalized based on the disease stage and liver condition, ranging from surgery to immunotherapy. Early detection significantly increases the chance of cure, although recurrence remains possible, particularly in chronic liver disease or cirrhosis patients. Regular follow-ups and liver check-ups are vital for ongoing health management.